ArticleProceedings of the National Academy of Sciences of the United States of America2014

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.

Markus Weiler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.